BRITTANY BOBROWSKI: Open Payments
NPI 1871900795 · BOONEVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 36 payments from 13 companies in 2025. Trend: 2023 $113 · 2024 $559 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $145 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $62 |
| PFIZER INC. | 4 | $61 |
| Lilly USA, LLC | 3 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| Dexcom, Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Baxter Healthcare | 1 | $28 |
Products named: CAPLYTA, AIRSUPRA, HETLIOZ, JOURNAVX, ELIQUIS, BREZTRI, LEQVIO, Dexcom G6 Transmitter.
Industry payments across KY — which companies pay providers there.
